Advertisement
Advertisement
U.S. Markets close in 4 hrs 37 mins
Advertisement
Advertisement
Advertisement
Advertisement

Humacyte, Inc. (HUMA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
9.92-0.30 (-2.90%)
As of 11:21AM EDT. Market open.
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close10.22
Open10.18
Bid9.90 x 3100
Ask9.93 x 1100
Day's Range9.77 - 10.25
52 Week Range9.12 - 17.45
Volume115,815
Avg. Volume249,228
Market CapN/A
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est19.00
  • GlobeNewswire

    Humacyte Announces Issuance of Three Additional U.S. Patents Covering its Proprietary Universally Implantable Bioengineered Human Tissue Platform

    Patent estate also expanded by the issuance of 23 additional patents in international marketsHumacyte now owns or licenses 119 patents covering its proprietary platform DURHAM, N.C., Sept. 20, 2021 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale, today announced the issuance of three additional U.S. patents covering its proprietary technology platform. Included in

  • GlobeNewswire

    Humacyte Leadership to Present at Five Scientific Events in September

    DURHAM, N.C., Sept. 17, 2021 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale, today announced that senior leadership will present at five scientific and medical events in September 2021. “We’re pioneering the first engineered off-the-shelf human acellular vessel (HAV) and are wholly committed to realizing the full potential of our HAV across a wide range of applica

Advertisement
Advertisement